These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 17037948

  • 1. Polycystic ovary syndrome in adolescents: current and future treatment options.
    Mastorakos G, Lambrinoudaki I, Creatsas G.
    Paediatr Drugs; 2006; 8(5):311-8. PubMed ID: 17037948
    [Abstract] [Full Text] [Related]

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [Abstract] [Full Text] [Related]

  • 3. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
    Spritzer PM, Motta AB.
    Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
    [Abstract] [Full Text] [Related]

  • 4. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
    Otto-Buczkowska E, Grzyb K, Jainta N.
    Pediatr Endocrinol Diabetes Metab; 2018 Nov; 24(1):40-44. PubMed ID: 30083660
    [Abstract] [Full Text] [Related]

  • 5. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 6. Insulin sensitizers in adolescents with polycystic ovary syndrome.
    LE TN, Wickham EP, Nestler JE.
    Minerva Pediatr; 2017 Oct 07; 69(5):434-443. PubMed ID: 28497664
    [Abstract] [Full Text] [Related]

  • 7. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 07; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 8. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D.
    Dan Med J; 2016 Apr 07; 63(4):. PubMed ID: 27034186
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E, Kiapekou E, Loutradis D.
    Pediatr Endocrinol Rev; 2006 Jan 07; 3 Suppl 1():208-13. PubMed ID: 16641862
    [Abstract] [Full Text] [Related]

  • 13. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L, Valls C, Potau N, Marcos MV, de Zegher F.
    J Clin Endocrinol Metab; 2000 Oct 07; 85(10):3526-30. PubMed ID: 11061495
    [Abstract] [Full Text] [Related]

  • 14. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI.
    J Clin Endocrinol Metab; 1999 Nov 07; 84(11):4006-11. PubMed ID: 10566641
    [Abstract] [Full Text] [Related]

  • 15. Polycystic ovary syndrome in adolescence.
    Driscoll DA.
    Ann N Y Acad Sci; 2003 Nov 07; 997():49-55. PubMed ID: 14644809
    [Abstract] [Full Text] [Related]

  • 16. Polycystic ovary syndrome in adolescence--a therapeutic conundrum.
    Homburg R, Lambalk CB.
    Hum Reprod; 2004 May 07; 19(5):1039-42. PubMed ID: 15016769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
    Stabile G, Borrielli I, Artenisio AC, Bruno LM, Benvenga S, Giunta L, La Marca A, Volpe A, Pizzo A.
    J Pediatr Adolesc Gynecol; 2014 Jun 07; 27(3):177-82. PubMed ID: 24814528
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovary syndrome in adolescents.
    Kent SC, Legro RS.
    Adolesc Med; 2002 Feb 07; 13(1):73-88, vi. PubMed ID: 11841956
    [Abstract] [Full Text] [Related]

  • 20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 07; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.